PHASE 1B/2A STUDY EVALUATING SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS RESPONSES OF THE ORAL TRANSFORMING GROWTH FACTOR-BETA (TGF-beta) RECEPTOR I KINASE INHIBITOR LY2157299 MONOHYDRATE COMBINED WITH CHEMORADIOTHERAPY IN NEWLY DIAGNOSED MALIGNANT GLIOMAS

NEURO-ONCOLOGY(2013)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要